56207-36-4

Usage

Uses

Used in Pharmaceutical Industry:
2'-METHYL-3'-NITROACETANILIDE is used as a chemical intermediate for the preparation of substituted pyrrolo[3,2-c]pyridin-4-amines, which are OGA (O-GlcNAcase) inhibitors. These inhibitors play a crucial role in the regulation of cellular signaling pathways and have potential applications in the treatment of various diseases, including diabetes and neurodegenerative disorders.

InChI:InChI=1/C9H10N2O3/c1-6-8(10-7(2)12)4-3-5-9(6)11(13)14/h3-5H,1-2H3,(H,10,12)

Upstream product

• 108-24-7 acetic anhydride 
• 603-83-8 3-nitro-o-tolylamine 
• 606-20-2 2,6-dinitrotoluene 

Downstream Products

• 70343-05-4 2-methyl-3,4-dinitro-aniline 
• 56207-39-7 2-methyl-3,6-dinitro-aniline 
• 56207-37-5 acetic acid-(2-methyl-3,4-dinitro-anilide) 
• 56207-38-6 acetic acid-(2-methyl-3,6-dinitro-anilide) 
• 619-15-8 2,5-dinitrotoluene 
• 602-01-7 1-methyl-2,3-dinitrobenzene 
• 18292-97-2 2,3,6-trinitrotoluene 

Relevant academic research and scientific papers

m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

A compound of formula I or of formula II wherein: R1 is F, Cl, Br, CH2F, CF2H, or CF3; R2 is NR6R7, where R6 is Me, Et, Pr, or iPr, and R7 is Me, Et or Pr; and R3, R4, and R5 independently of one another each are H, Me, F, Cl, Br, CH2F, CF2H, or CF3, and if R4 is Me, F, Cl, Br, CH2F, CF2H, or CF3, then R1 is additionally H or Me, or a pharmacologically acceptable salt thereof. In addition, pharmaceutical compositions comprising an effective amount of these compounds, methods for the treatment or prophylaxis of urinary incontinence and diseases of the bladder using these compounds, and methods for making these compounds are disclosed.

Methods for dyeing keratinous fibres with aminoindoles, compositions and devices for use

Method for dyeing keratinous fibres, in particular human keratinous fibres, such as hair, characterized in that a composition (A) containing, in a medium appropriate for dyeing, at least one aminoindole corresponding to the formula: STR1 in which: R1 and R3, independently of one another, represent a hydrogen atom or a C1 -C4 alkyl group; R2 denotes hydrogen or a C1 -C4 alkyl group or COOR', R' being a hydrogen atom or a C1 -C4 alkyl group; R4 represents a hydrogen atom or a C1 -C4 alkyl, C1 -C4 hydroxyalkyl or C2 -C4 polyhydroxyalkyl group; Z1 represents a hydrogen or halogen atom or a C1 -C4 alkyl group or OR; R being a hydrogen atom or a C1 -C4 alkyl group; and Z2 represents a hydrogen atom or a C1 -C4 alkyl group; and its salts is applied to said fibres, the colour being developed with the aid of an oxidizing system.